Trigger Factors and Effects of Alzheimer's Disease





Alzheimer's Disease, Genetic Factors, Environmental Risk Factors, Genetics, Neurobiological Pathways


Alzheimer's Disease is a neurodegenerative disorder characterised by symptoms such as cognitive decline, memory loss and decreased activities of daily living. Factors that play a role in the development of this disease include genetic, environmental and neurobiological factors. The importance of genetic factors has been associated with early onset of the disease and family history. Environmental factors include lifestyle factors such as toxic metals, pesticides, nutrition, exercise and sleep patterns. Neurobiological mechanisms include amyloid cascade hypothesis, hyperphosphorylation of tau proteins, oxidative stress and inflammation. Alzheimer's Disease is diagnosed through clinical assessments and cognitive testing, and treatment options focus on symptom relief. Future research should aim to deepen our understanding of the aetiology and pathogenesis of the disease and develop more effective treatment and prevention strategies. The complex nature of Alzheimer's Disease is determined by the interaction of genetic, environmental and neurobiological factors and understanding these factors plays an important role in the management of the disease.


Dharmaraj GL, Arigo FD, Young KA, Martins R, Mancera RL, Bharadwaj P. Novel Amylin Analogues Reduce Amyloid-β Cross-Seeding Aggregation and Neurotoxicity. J Alzheimers Dis. 2022;87(1):373-390. doi:10.3233/JAD-215339

Nikolac Perkovic M, Pivac N. Genetic Markers of Alzheimer's Disease. Adv Exp Med Biol. 2019;1192:27-52. doi:10.1007/978-981-32-9721-0_3

Breijyeh Z, Karaman R. Comprehensive Review on Alzheimer's Disease: Causes and Treatment. Molecules. 2020;25(24):5789. Published 2020 Dec 8. doi:10.3390/molecules25245789

Yegambaram M, Manivannan B, Beach TG, Halden RU. Role of environmental contaminants in the etiology of Alzheimer's disease: a review. Curr Alzheimer Res. 2015;12(2):116-146. doi:10.2174/1567205012666150204121719

Zhang XX, Tian Y, Wang ZT, Ma YH, Tan L, Yu JT. The Epidemiology of Alzheimer's Disease Modifiable Risk Factors and Prevention. J Prev Alzheimers Dis. 2021;8(3):313-321. doi:10.14283/jpad.2021.15

de Paula VJR, Guimarães FM, Diniz BS, Forlenza OV. Neurobiological pathways to Alzheimer's disease: Amyloid-beta, TAU protein or both?. Dement Neuropsychol. 2009;3(3):188-194. doi:10.1590/S1980-57642009DN30300003

Al-Ghraiybah NF, Wang J, Alkhalifa AE, et al. Glial Cell-Mediated Neuroinflammation in Alzheimer's Disease. Int J Mol Sci. 2022;23(18):10572. Published 2022 Sep 12. doi:10.3390/ijms231810572

Bai R, Guo J, Ye XY, Xie Y, Xie T. Oxidative stress: The core pathogenesis and mechanism of Alzheimer's disease. Ageing Res Rev. 2022;77:101619. doi:10.1016/j.arr.2022.101619

Scheltens P, De Strooper B, Kivipelto M, et al. Alzheimer's disease. Lancet. 2021;397(10284):1577-1590. doi:10.1016/S0140-6736(20)32205-4

Dubois B, von Arnim CAF, Burnie N, Bozeat S, Cummings J. Biomarkers in Alzheimer's disease: role in early and differential diagnosis and recognition of atypical variants. Alzheimers Res Ther. 2023;15(1):175. Published 2023 Oct 13. doi:10.1186/s13195-023-01314-6

Mantzavinos V, Alexiou A. Biomarkers for Alzheimer's Disease Diagnosis. Curr Alzheimer Res. 2017;14(11):1149-1154. doi:10.2174/1567205014666170203125942

Passeri E, Elkhoury K, Morsink M, et al. Alzheimer's Disease: Treatment Strategies and Their Limitations. Int J Mol Sci. 2022;23(22):13954. Published 2022 Nov 12. doi:10.3390/ijms232213954

Athar T, Al Balushi K, Khan SA. Recent advances on drug development and emerging therapeutic agents for Alzheimer's disease. Mol Biol Rep. 2021;48(7):5629-5645. doi:10.1007/s11033-021-06512-9

Lane CA, Hardy J, Schott JM. Alzheimer's disease. Eur J Neurol. 2018;25(1):59-70. doi:10.1111/ene.13439




How to Cite

Erdoğdu, Şükran. (2024). Trigger Factors and Effects of Alzheimer’s Disease: Review. Europeanatolia Health Sciences Journal, 2(1), 01–03.